Italy· 036160202
ADVATE*1 flaconcino EV 1.500 Unita' Internazionali + 1 flaconcino solv 2 ml preassemblati con dispositivo per ricostituzione
A medicinal product containing octocog alfa (fattore viii di coagulazione, ricombinante), registered in Italy by TAKEDA MANUFACTURING AUS. AG, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Octocog alfa (Fattore VIII di coagulazione, ricombinante)
- Manufacturer
- TAKEDA MANUFACTURING AUS. AG
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic036160202ADVATE*1 flaconcino EV 1.500 Unita' Internazionali + 1 flaconcino solv 2 ml preassemblati con dispositivo per ricostituzioneEUR 1609.14
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Octocog alfa (fattore viii di coagulazione, ricombinante) in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumAdvate 1000 IUTakeda Austria
- CzechiaADVATETakeda Manufacturing Austria AG, Vídeň
- SpainADVATE 1.000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLETakeda Manufacturing Austria Ag
- FinlandAdvateAbacus Medicine A/S
- United KingdomAdvate 1,000unit powder and solvent for solution for injection vialsTakeda UK Ltd
- IrelandAdvate 1000 IU/2 ml powder and solvent for solution for injectionTakeda Manufacturing Austria AG
- NetherlandsAdvate 1000 IU, poeder en oplosmiddel voor oplossing voor injectie 200 IU/mlTakeda Manufacturing Austria AG
- SwedenADVATE 1000 IE (2 ml) Pulver och vätska till injektionsvätska, lösningTakeda Manufacturing Austria AG
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Germany · Recombinate
- Iceland · Advate, Kovaltry
- Liechtenstein · Advate, Kovaltry
- Lithuania · Recombinate
- Netherlands · Recombinate
- Norway · Advate, Kovaltry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f5fab988-14e6-48df-ac84-65a7a29ed976 GET /v1/drugs/f5fab988-14e6-48df-ac84-65a7a29ed976?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 1609.14,
"source": "aifa",
"currency": "EUR",
"strength": "OCTOCOG ALFA III GENERAZIONE 1.500UI 1 UNITA' USO PARENTERALE",
"substance": "Octocog alfa (Fattore VIII di coagulazione, ricombinante)",
"equivalence_group": "LME",
"transparency_flag": null
}See everything about octocog alfa (fattore viii di coagulazione, ricombinante).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.